Eschatin Specifically Indicated in Addison's Disease Parke Davis Ink Blotter

pdib-002a-eschatin.jpg

Title

Eschatin Specifically Indicated in Addison's Disease Parke Davis Ink Blotter

Description

Parke Davis collectible ink blotter from the 1940s advertising Eschatin, specifically indicated in Addison's Disease. This potent cortical extract is also used to correct adrenal insufficiency in the following conditions: asthenia, shock, infectious diseases, toxemias of pregnancy, febrile diseases. Eschatin may be given by subcutaneous, intramuscular, or intravenous injection; the intravenous method is recommended for emergencies only. The blotter is stamped June 29, 1943. The Parke-Davis identifier is bl-101-1.

Date

Rights

Copyright undetermined. For more information or for high-quality reproductions, please contact AIHP: aihp@aihp.org.
https://rightsstatements.org/page/UND/1.0/

Format

Language

eng

Identifier

pdib-002-eschatin
bl-101-1

Extent

7 X 3.5 inches

Temporal Coverage

Citation

Parke, Davis & Company, “Eschatin Specifically Indicated in Addison's Disease Parke Davis Ink Blotter,” American Institute of the History of Pharmacy Digital Collection, accessed August 9, 2022, https://aihp.omeka.net/items/show/169.